Summit Therapeutics Inc (NASDAQ: SMMT) Is Under Pressure Due To Weak Fundamental Momentum.
In the latest trading session, 2.25 million Summit Therapeutics Inc (NASDAQ:SMMT) shares changed hands as the company’s beta touched -1.06. With the company’s most recent